APO Research
Talk to an analyst

APO RESEARCH · REPORT

E. coli Competent Cells

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global E. coli Competent Cells Market Outlook and Growth Opportunities 2026

26 December 2025219 pages

Choose your research edition.

Industry ResearchE. coli Competent Cells Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal E. coli Competent Cells Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal E. coli Competent Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal E. coli Competent Cells Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal E. coli Competent Cells Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global E. coli Competent Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for E. coli Competent Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the E. coli Competent Cells market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the E. coli Competent Cells market include Addgene, Agilent, Beijing TransGen Biotech, Bioline, Bio-Rad, GCC Biotech, GenScript, IBA and LGC Biosearch Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global E. coli Competent Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of E. coli Competent Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents E. coli Competent Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the E. coli Competent Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

E. coli Competent Cells Segment by Company

Addgene

Agilent

Beijing TransGen Biotech

Bioline

Bio-Rad

GCC Biotech

GenScript

IBA

LGC Biosearch Technologies

New England Biolabs

New England Biolabs (NEB)

Promega Corporation

QIAGEN

Scarab Genomics

Takara Bio

Zymo Research

Beyotime

Maokangbio

Merck

Thermo Fisher Scientific

TIANGEN

NCM Biotech

Yeasen

ZOMANBIO

E. coli Competent Cells Segment by Type

Chemically Competent Cells

Electrocompetent Cells

E. coli Competent Cells Segment by Application

Cloning

Proteomics

Genomics

E. coli Competent Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global E. coli Competent Cells status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions E. coli Competent Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify E. coli Competent Cells significant trends, drivers, influence factors in global and regions.

6. To analyze E. coli Competent Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global E. coli Competent Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of E. coli Competent Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of E. coli Competent Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the E. coli Competent Cells market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global E. coli Competent Cells industry.

Chapter 3: Detailed analysis of E. coli Competent Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of E. coli Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of E. coli Competent Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. E. coli Competent Cells Industry Trends Table 2. E. coli Competent Cells Industry Drivers Table 3. E. coli Competent Cells Industry Opportunities and Challenges Table 4. E. coli Competent Cells Industry Restraints Table 5. Global E. coli Competent Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global E. coli Competent Cells Revenue Share by Company (2021-2026) Table 7. Global E. coli Competent Cells Sales Volume by Company (K Units) & (2021-2026) Table 8. Global E. coli Competent Cells Sales Volume Share by Company (2021-2026) Table 9. Global E. coli Competent Cells Average Price (US$/Unit) of Company (2021-2026) Table 10. Global E. coli Competent Cells Company Ranking, (2024-2026) & (USD Million) Table 11. Global E. coli Competent Cells Key Company Manufacturing Base & Headquarters Table 12. Global E. coli Competent Cells Company, Product Type & Application Table 13. Global E. coli Competent Cells Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global E. coli Competent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Chemically Competent Cells Table 18. Significant Companies of Electrocompetent Cells Table 19. Global E. coli Competent Cells Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global E. coli Competent Cells Sales Volume by Type (2021-2026) & (K Units) Table 21. Global E. coli Competent Cells Sales Volume by Type (2027-2032) & (K Units) Table 22. Global E. coli Competent Cells Sales Volume Share by Type (2021-2026) Table 23. Global E. coli Competent Cells Sales Volume Share by Type (2027-2032) Table 24. Global E. coli Competent Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global E. coli Competent Cells Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global E. coli Competent Cells Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global E. coli Competent Cells Sales Value Share by Type (2021-2026) Table 28. Global E. coli Competent Cells Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cloning Table 30. Significant Companies of Proteomics Table 31. Significant Companies of Genomics Table 32. Global E. coli Competent Cells Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global E. coli Competent Cells Sales Volume by Application (2021-2026) & (K Units) Table 34. Global E. coli Competent Cells Sales Volume by Application (2027-2032) & (K Units) Table 35. Global E. coli Competent Cells Sales Volume Share by Application (2021-2026) Table 36. Global E. coli Competent Cells Sales Volume Share by Application (2027-2032) Table 37. Global E. coli Competent Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global E. coli Competent Cells Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global E. coli Competent Cells Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global E. coli Competent Cells Sales Value Share by Application (2021-2026) Table 41. Global E. coli Competent Cells Sales Value Share by Application (2027-2032) Table 42. Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global E. coli Competent Cells Sales by Region (2021-2026) & (K Units) Table 44. Global E. coli Competent Cells Sales Market Share by Region (2021-2026) Table 45. Global E. coli Competent Cells Sales by Region (2027-2032) & (K Units) Table 46. Global E. coli Competent Cells Sales Market Share by Region (2027-2032) Table 47. Global E. coli Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global E. coli Competent Cells Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global E. coli Competent Cells Sales Value Share by Region (2021-2026) Table 50. Global E. coli Competent Cells Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global E. coli Competent Cells Sales Value Share by Region (2027-2032) Table 52. Global E. coli Competent Cells Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global E. coli Competent Cells Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global E. coli Competent Cells Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global E. coli Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global E. coli Competent Cells Sales by Country (2021-2026) & (K Units) Table 57. Global E. coli Competent Cells Sales Market Share by Country (2021-2026) Table 58. Global E. coli Competent Cells Sales by Country (2027-2032) & (K Units) Table 59. Global E. coli Competent Cells Sales Market Share by Country (2027-2032) Table 60. Global E. coli Competent Cells Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global E. coli Competent Cells Sales Value Market Share by Country (2021-2026) Table 62. Global E. coli Competent Cells Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global E. coli Competent Cells Sales Value Market Share by Country (2027-2032) Table 64. Addgene Company Information Table 65. Addgene Business Overview Table 66. Addgene E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Addgene E. coli Competent Cells Product Portfolio Table 68. Addgene Recent Development Table 69. Agilent Company Information Table 70. Agilent Business Overview Table 71. Agilent E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Agilent E. coli Competent Cells Product Portfolio Table 73. Agilent Recent Development Table 74. Beijing TransGen Biotech Company Information Table 75. Beijing TransGen Biotech Business Overview Table 76. Beijing TransGen Biotech E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Beijing TransGen Biotech E. coli Competent Cells Product Portfolio Table 78. Beijing TransGen Biotech Recent Development Table 79. Bioline Company Information Table 80. Bioline Business Overview Table 81. Bioline E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bioline E. coli Competent Cells Product Portfolio Table 83. Bioline Recent Development Table 84. Bio-Rad Company Information Table 85. Bio-Rad Business Overview Table 86. Bio-Rad E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bio-Rad E. coli Competent Cells Product Portfolio Table 88. Bio-Rad Recent Development Table 89. GCC Biotech Company Information Table 90. GCC Biotech Business Overview Table 91. GCC Biotech E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. GCC Biotech E. coli Competent Cells Product Portfolio Table 93. GCC Biotech Recent Development Table 94. GenScript Company Information Table 95. GenScript Business Overview Table 96. GenScript E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. GenScript E. coli Competent Cells Product Portfolio Table 98. GenScript Recent Development Table 99. IBA Company Information Table 100. IBA Business Overview Table 101. IBA E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. IBA E. coli Competent Cells Product Portfolio Table 103. IBA Recent Development Table 104. LGC Biosearch Technologies Company Information Table 105. LGC Biosearch Technologies Business Overview Table 106. LGC Biosearch Technologies E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. LGC Biosearch Technologies E. coli Competent Cells Product Portfolio Table 108. LGC Biosearch Technologies Recent Development Table 109. New England Biolabs Company Information Table 110. New England Biolabs Business Overview Table 111. New England Biolabs E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. New England Biolabs E. coli Competent Cells Product Portfolio Table 113. New England Biolabs Recent Development Table 114. New England Biolabs (NEB) Company Information Table 115. New England Biolabs (NEB) Business Overview Table 116. New England Biolabs (NEB) E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. New England Biolabs (NEB) E. coli Competent Cells Product Portfolio Table 118. New England Biolabs (NEB) Recent Development Table 119. Promega Corporation Company Information Table 120. Promega Corporation Business Overview Table 121. Promega Corporation E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Promega Corporation E. coli Competent Cells Product Portfolio Table 123. Promega Corporation Recent Development Table 124. QIAGEN Company Information Table 125. QIAGEN Business Overview Table 126. QIAGEN E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. QIAGEN E. coli Competent Cells Product Portfolio Table 128. QIAGEN Recent Development Table 129. Scarab Genomics Company Information Table 130. Scarab Genomics Business Overview Table 131. Scarab Genomics E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Scarab Genomics E. coli Competent Cells Product Portfolio Table 133. Scarab Genomics Recent Development Table 134. Takara Bio Company Information Table 135. Takara Bio Business Overview Table 136. Takara Bio E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Takara Bio E. coli Competent Cells Product Portfolio Table 138. Takara Bio Recent Development Table 139. Zymo Research Company Information Table 140. Zymo Research Business Overview Table 141. Zymo Research E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Zymo Research E. coli Competent Cells Product Portfolio Table 143. Zymo Research Recent Development Table 144. Beyotime Company Information Table 145. Beyotime Business Overview Table 146. Beyotime E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Beyotime E. coli Competent Cells Product Portfolio Table 148. Beyotime Recent Development Table 149. Maokangbio Company Information Table 150. Maokangbio Business Overview Table 151. Maokangbio E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Maokangbio E. coli Competent Cells Product Portfolio Table 153. Maokangbio Recent Development Table 154. Merck Company Information Table 155. Merck Business Overview Table 156. Merck E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Merck E. coli Competent Cells Product Portfolio Table 158. Merck Recent Development Table 159. Thermo Fisher Scientific Company Information Table 160. Thermo Fisher Scientific Business Overview Table 161. Thermo Fisher Scientific E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Thermo Fisher Scientific E. coli Competent Cells Product Portfolio Table 163. Thermo Fisher Scientific Recent Development Table 164. TIANGEN Company Information Table 165. TIANGEN Business Overview Table 166. TIANGEN E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. TIANGEN E. coli Competent Cells Product Portfolio Table 168. TIANGEN Recent Development Table 169. NCM Biotech Company Information Table 170. NCM Biotech Business Overview Table 171. NCM Biotech E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. NCM Biotech E. coli Competent Cells Product Portfolio Table 173. NCM Biotech Recent Development Table 174. Yeasen Company Information Table 175. Yeasen Business Overview Table 176. Yeasen E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 177. Yeasen E. coli Competent Cells Product Portfolio Table 178. Yeasen Recent Development Table 179. ZOMANBIO Company Information Table 180. ZOMANBIO Business Overview Table 181. ZOMANBIO E. coli Competent Cells Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 182. ZOMANBIO E. coli Competent Cells Product Portfolio Table 183. ZOMANBIO Recent Development Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. E. coli Competent Cells Distributors List Table 187. E. coli Competent Cells Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. E. coli Competent Cells Product Image Figure 2. Global E. coli Competent Cells Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 4. Global E. coli Competent Cells Sales (2021-2032) & (K Units) Figure 5. Global E. coli Competent Cells Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global E. coli Competent Cells Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Chemically Competent Cells Image Figure 10. Electrocompetent Cells Image Figure 11. Global E. coli Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global E. coli Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global E. coli Competent Cells Sales Volume Share by Type (2021-2032) Figure 14. Global E. coli Competent Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global E. coli Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global E. coli Competent Cells Sales Value Share by Type (2021-2032) Figure 17. Cloning Image Figure 18. Proteomics Image Figure 19. Genomics Image Figure 20. Global E. coli Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global E. coli Competent Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global E. coli Competent Cells Sales Volume Share by Application (2021-2032) Figure 23. Global E. coli Competent Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global E. coli Competent Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global E. coli Competent Cells Sales Value Share by Application (2021-2032) Figure 26. Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global E. coli Competent Cells Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global E. coli Competent Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global E. coli Competent Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 31. North America E. coli Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 33. Europe E. coli Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific E. coli Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 37. South America E. coli Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa E. coli Competent Cells Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa E. coli Competent Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt E. coli Competent Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. E. coli Competent Cells Value Chain Figure 125. Manufacturing Cost Structure Figure 126. E. coli Competent Cells Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Chemically Competent Cells
  • Electrocompetent Cells
Applications
  • Cloning
  • Proteomics
  • Genomics
Companies covered
  • Addgene
  • Agilent
  • Beijing TransGen Biotech
  • Bioline
  • Bio-Rad
  • GCC Biotech
  • GenScript
  • IBA
  • LGC Biosearch Technologies
  • New England Biolabs
  • New England Biolabs (NEB)
  • Promega Corporation
  • QIAGEN
  • Scarab Genomics
  • Takara Bio
  • Zymo Research
  • Beyotime
  • Maokangbio
  • Merck
  • Thermo Fisher Scientific
  • TIANGEN
  • NCM Biotech
  • Yeasen
  • ZOMANBIO

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global E. coli Competent Cells Sales Value (2021-2032)
  4. 1.2.2 Global E. coli Competent Cells Sales Volume (2021-2032)
  5. 1.2.3 Global E. coli Competent Cells Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 E. coli Competent Cells Market Dynamics
  1. 2.1 E. coli Competent Cells Industry Trends
  2. 2.2 E. coli Competent Cells Industry Drivers
  3. 2.3 E. coli Competent Cells Industry Opportunities and Challenges
  4. 2.4 E. coli Competent Cells Industry Restraints
3 E. coli Competent Cells Market by Company
  1. 3.1 Global E. coli Competent Cells Company Revenue Ranking in 2025
  2. 3.2 Global E. coli Competent Cells Revenue by Company (2021-2026)
  3. 3.3 Global E. coli Competent Cells Sales Volume by Company (2021-2026)
  4. 3.4 Global E. coli Competent Cells Average Price by Company (2021-2026)
  5. 3.5 Global E. coli Competent Cells Company Ranking (2024-2026)
  6. 3.6 Global E. coli Competent Cells Company Manufacturing Base and Headquarters
  7. 3.7 Global E. coli Competent Cells Company Product Type and Application
  8. 3.8 Global E. coli Competent Cells Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global E. coli Competent Cells Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 E. coli Competent Cells Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 E. coli Competent Cells Market by Type
  1. 4.1 E. coli Competent Cells Type Introduction
  2. 4.1.1 Chemically Competent Cells
  3. 4.1.2 Electrocompetent Cells
  4. 4.2 Global E. coli Competent Cells Sales Volume by Type
  5. 4.2.1 Global E. coli Competent Cells Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global E. coli Competent Cells Sales Volume by Type (2021-2032)
  7. 4.2.3 Global E. coli Competent Cells Sales Volume Share by Type (2021-2032)
  8. 4.3 Global E. coli Competent Cells Sales Value by Type
  9. 4.3.1 Global E. coli Competent Cells Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global E. coli Competent Cells Sales Value by Type (2021-2032)
  11. 4.3.3 Global E. coli Competent Cells Sales Value Share by Type (2021-2032)
5 E. coli Competent Cells Market by Application
  1. 5.1 E. coli Competent Cells Application Introduction
  2. 5.1.1 Cloning
  3. 5.1.2 Proteomics
  4. 5.1.3 Genomics
  5. 5.2 Global E. coli Competent Cells Sales Volume by Application
  6. 5.2.1 Global E. coli Competent Cells Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global E. coli Competent Cells Sales Volume by Application (2021-2032)
  8. 5.2.3 Global E. coli Competent Cells Sales Volume Share by Application (2021-2032)
  9. 5.3 Global E. coli Competent Cells Sales Value by Application
  10. 5.3.1 Global E. coli Competent Cells Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global E. coli Competent Cells Sales Value by Application (2021-2032)
  12. 5.3.3 Global E. coli Competent Cells Sales Value Share by Application (2021-2032)
6 E. coli Competent Cells Regional Sales and Value Analysis
  1. 6.1 Global E. coli Competent Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global E. coli Competent Cells Sales by Region (2021-2032)
  3. 6.2.1 Global E. coli Competent Cells Sales by Region: 2021-2026
  4. 6.2.2 Global E. coli Competent Cells Sales by Region (2027-2032)
  5. 6.3 Global E. coli Competent Cells Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global E. coli Competent Cells Sales Value by Region (2021-2032)
  7. 6.4.1 Global E. coli Competent Cells Sales Value by Region: 2021-2026
  8. 6.4.2 Global E. coli Competent Cells Sales Value by Region (2027-2032)
  9. 6.5 Global E. coli Competent Cells Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America E. coli Competent Cells Sales Value (2021-2032)
  12. 6.6.2 North America E. coli Competent Cells Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe E. coli Competent Cells Sales Value (2021-2032)
  15. 6.7.2 Europe E. coli Competent Cells Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific E. coli Competent Cells Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific E. coli Competent Cells Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America E. coli Competent Cells Sales Value (2021-2032)
  21. 6.9.2 South America E. coli Competent Cells Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa E. coli Competent Cells Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa E. coli Competent Cells Sales Value Share by Country, 2025 VS 2032
7 E. coli Competent Cells Country-level Sales and Value Analysis
  1. 7.1 Global E. coli Competent Cells Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global E. coli Competent Cells Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global E. coli Competent Cells Sales by Country (2021-2032)
  4. 7.3.1 Global E. coli Competent Cells Sales by Country (2021-2026)
  5. 7.3.2 Global E. coli Competent Cells Sales by Country (2027-2032)
  6. 7.4 Global E. coli Competent Cells Sales Value by Country (2021-2032)
  7. 7.4.1 Global E. coli Competent Cells Sales Value by Country (2021-2026)
  8. 7.4.2 Global E. coli Competent Cells Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt E. coli Competent Cells Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt E. coli Competent Cells Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt E. coli Competent Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Addgene
  2. 8.1.1 Addgene Company Information
  3. 8.1.2 Addgene Business Overview
  4. 8.1.3 Addgene E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Addgene E. coli Competent Cells Product Portfolio
  6. 8.1.5 Addgene Recent Developments
  7. 8.2 Agilent
  8. 8.2.1 Agilent Company Information
  9. 8.2.2 Agilent Business Overview
  10. 8.2.3 Agilent E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Agilent E. coli Competent Cells Product Portfolio
  12. 8.2.5 Agilent Recent Developments
  13. 8.3 Beijing TransGen Biotech
  14. 8.3.1 Beijing TransGen Biotech Company Information
  15. 8.3.2 Beijing TransGen Biotech Business Overview
  16. 8.3.3 Beijing TransGen Biotech E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beijing TransGen Biotech E. coli Competent Cells Product Portfolio
  18. 8.3.5 Beijing TransGen Biotech Recent Developments
  19. 8.4 Bioline
  20. 8.4.1 Bioline Company Information
  21. 8.4.2 Bioline Business Overview
  22. 8.4.3 Bioline E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bioline E. coli Competent Cells Product Portfolio
  24. 8.4.5 Bioline Recent Developments
  25. 8.5 Bio-Rad
  26. 8.5.1 Bio-Rad Company Information
  27. 8.5.2 Bio-Rad Business Overview
  28. 8.5.3 Bio-Rad E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad E. coli Competent Cells Product Portfolio
  30. 8.5.5 Bio-Rad Recent Developments
  31. 8.6 GCC Biotech
  32. 8.6.1 GCC Biotech Company Information
  33. 8.6.2 GCC Biotech Business Overview
  34. 8.6.3 GCC Biotech E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GCC Biotech E. coli Competent Cells Product Portfolio
  36. 8.6.5 GCC Biotech Recent Developments
  37. 8.7 GenScript
  38. 8.7.1 GenScript Company Information
  39. 8.7.2 GenScript Business Overview
  40. 8.7.3 GenScript E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GenScript E. coli Competent Cells Product Portfolio
  42. 8.7.5 GenScript Recent Developments
  43. 8.8 IBA
  44. 8.8.1 IBA Company Information
  45. 8.8.2 IBA Business Overview
  46. 8.8.3 IBA E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 IBA E. coli Competent Cells Product Portfolio
  48. 8.8.5 IBA Recent Developments
  49. 8.9 LGC Biosearch Technologies
  50. 8.9.1 LGC Biosearch Technologies Company Information
  51. 8.9.2 LGC Biosearch Technologies Business Overview
  52. 8.9.3 LGC Biosearch Technologies E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 LGC Biosearch Technologies E. coli Competent Cells Product Portfolio
  54. 8.9.5 LGC Biosearch Technologies Recent Developments
  55. 8.10 New England Biolabs
  56. 8.10.1 New England Biolabs Company Information
  57. 8.10.2 New England Biolabs Business Overview
  58. 8.10.3 New England Biolabs E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 New England Biolabs E. coli Competent Cells Product Portfolio
  60. 8.10.5 New England Biolabs Recent Developments
  61. 8.11 New England Biolabs (NEB)
  62. 8.11.1 New England Biolabs (NEB) Company Information
  63. 8.11.2 New England Biolabs (NEB) Business Overview
  64. 8.11.3 New England Biolabs (NEB) E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 New England Biolabs (NEB) E. coli Competent Cells Product Portfolio
  66. 8.11.5 New England Biolabs (NEB) Recent Developments
  67. 8.12 Promega Corporation
  68. 8.12.1 Promega Corporation Company Information
  69. 8.12.2 Promega Corporation Business Overview
  70. 8.12.3 Promega Corporation E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Promega Corporation E. coli Competent Cells Product Portfolio
  72. 8.12.5 Promega Corporation Recent Developments
  73. 8.13 QIAGEN
  74. 8.13.1 QIAGEN Company Information
  75. 8.13.2 QIAGEN Business Overview
  76. 8.13.3 QIAGEN E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 QIAGEN E. coli Competent Cells Product Portfolio
  78. 8.13.5 QIAGEN Recent Developments
  79. 8.14 Scarab Genomics
  80. 8.14.1 Scarab Genomics Company Information
  81. 8.14.2 Scarab Genomics Business Overview
  82. 8.14.3 Scarab Genomics E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Scarab Genomics E. coli Competent Cells Product Portfolio
  84. 8.14.5 Scarab Genomics Recent Developments
  85. 8.15 Takara Bio
  86. 8.15.1 Takara Bio Company Information
  87. 8.15.2 Takara Bio Business Overview
  88. 8.15.3 Takara Bio E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Takara Bio E. coli Competent Cells Product Portfolio
  90. 8.15.5 Takara Bio Recent Developments
  91. 8.16 Zymo Research
  92. 8.16.1 Zymo Research Company Information
  93. 8.16.2 Zymo Research Business Overview
  94. 8.16.3 Zymo Research E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Zymo Research E. coli Competent Cells Product Portfolio
  96. 8.16.5 Zymo Research Recent Developments
  97. 8.17 Beyotime
  98. 8.17.1 Beyotime Company Information
  99. 8.17.2 Beyotime Business Overview
  100. 8.17.3 Beyotime E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Beyotime E. coli Competent Cells Product Portfolio
  102. 8.17.5 Beyotime Recent Developments
  103. 8.18 Maokangbio
  104. 8.18.1 Maokangbio Company Information
  105. 8.18.2 Maokangbio Business Overview
  106. 8.18.3 Maokangbio E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Maokangbio E. coli Competent Cells Product Portfolio
  108. 8.18.5 Maokangbio Recent Developments
  109. 8.19 Merck
  110. 8.19.1 Merck Company Information
  111. 8.19.2 Merck Business Overview
  112. 8.19.3 Merck E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Merck E. coli Competent Cells Product Portfolio
  114. 8.19.5 Merck Recent Developments
  115. 8.20 Thermo Fisher Scientific
  116. 8.20.1 Thermo Fisher Scientific Company Information
  117. 8.20.2 Thermo Fisher Scientific Business Overview
  118. 8.20.3 Thermo Fisher Scientific E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Thermo Fisher Scientific E. coli Competent Cells Product Portfolio
  120. 8.20.5 Thermo Fisher Scientific Recent Developments
  121. 8.21 TIANGEN
  122. 8.21.1 TIANGEN Company Information
  123. 8.21.2 TIANGEN Business Overview
  124. 8.21.3 TIANGEN E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 TIANGEN E. coli Competent Cells Product Portfolio
  126. 8.21.5 TIANGEN Recent Developments
  127. 8.22 NCM Biotech
  128. 8.22.1 NCM Biotech Company Information
  129. 8.22.2 NCM Biotech Business Overview
  130. 8.22.3 NCM Biotech E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 NCM Biotech E. coli Competent Cells Product Portfolio
  132. 8.22.5 NCM Biotech Recent Developments
  133. 8.23 Yeasen
  134. 8.23.1 Yeasen Company Information
  135. 8.23.2 Yeasen Business Overview
  136. 8.23.3 Yeasen E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Yeasen E. coli Competent Cells Product Portfolio
  138. 8.23.5 Yeasen Recent Developments
  139. 8.24 ZOMANBIO
  140. 8.24.1 ZOMANBIO Company Information
  141. 8.24.2 ZOMANBIO Business Overview
  142. 8.24.3 ZOMANBIO E. coli Competent Cells Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 ZOMANBIO E. coli Competent Cells Product Portfolio
  144. 8.24.5 ZOMANBIO Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 E. coli Competent Cells Value Chain Analysis
  2. 9.1.1 E. coli Competent Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 E. coli Competent Cells Sales Mode & Process
  6. 9.2 E. coli Competent Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 E. coli Competent Cells Distributors
  9. 9.2.3 E. coli Competent Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst